AirNexis Therapeutics Funding: $200M Raised, Series A (2026)
AirNexis Therapeutics is based in Palo Alto, California. It has raised $200M in total funding. Latest round: Series A. Backed by Frazier Life Sciences.
AirNexis Therapeutics funding overview
AirNexis Therapeutics is based in Palo Alto, California. AirNexis Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2026. The round record for AirNexis Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Frazier Life Sciences.
AirNexis Therapeutics at a glance
Total raised
$200M
Latest round
Series A
Latest round date
January 2026
Headquarters
Palo Alto, California
Notable investors
Frazier Life Sciences
Frequently asked about AirNexis Therapeutics funding
How much has AirNexis Therapeutics raised?
AirNexis Therapeutics has raised $200M in total disclosed funding across the rounds on record.
Who has invested in AirNexis Therapeutics?
Frazier Life Sciences are named among the investors backing AirNexis Therapeutics.
What was the latest AirNexis Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2026.
Where is AirNexis Therapeutics based?
AirNexis Therapeutics is based in Palo Alto, California.
When did AirNexis Therapeutics last raise?
The last disclosed AirNexis Therapeutics round closed in January 2026 at Series A.
Every AirNexis Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Palo Alto at a similar stage.
